C O M M U N I C A T I O N S
Figure 3. Uncaging copper from [Cu(cage)] in pH 7.4 phosphate buffer
by UV photolysis increases OH• production as measured by the increase in
A532 for deoxyribose degradation. A and A0 are the absorbance with and
without ligand, so A/A0 ) 1 for CuSO4 alone; lower values indicate an
inhibitory effect and higher values indicate a promotional effect of the ligand
with respect to copper’s reactivity for OH• production. [Cu(cage)]* was
photolyzed for 4 min.
Figure 2. Chromatography traces for H2cage (top), [Cu(cage)], authentic
picolinamide, and [Cu(cage)] after 4 min of UV photolysis (bottom). Mass
spectra corresponding to the LC peaks confirm the identity of ligand 1,
copper complex 2, and photoproducts 3 and 4 (see SI).
is likely bound to these photoproducts in solution, but with
significantly diminished affinity compared to the intact ligand 1,
as the log ꢀ values for picolinamide are only 2.87 and 5.40 for the
1:1 and 1:2 species.12 Reduction to Cu1+ is also possible as a result
of photolysis, although it would likely reoxidize to Cu2+ under
these experimental conditions.
ligands to other biologically interesting metals. These new reagents
will be valuable tools for on-demand delivery of metal ions to study
mechanisms of metal ion trafficking, as well as applications such
as chemotherapy where toxic metal ions could be released to induce
cell death.
To show that photolysis of [Cu(OH2)(cage)] causes a change in
the reactivity of the caged versus uncaged copper, we monitored
the ability of the compounds pre- and postphotolysis to generate
OH• radicals by subjecting them to the deoxyribose assay. Hydroxyl
radicals, which are generated in this assay by Fenton-like conditions
of copper, ascorbic acid, and H2O2, degrade deoxyribose to give
thiobarbituric acid (TBA)-reactive products with absorbance at 532
nm (SI). Ligands added to the reaction mixture attenuate the amount
of TBA-reactive species by altering the coordination environment
around copper. As shown in Figure 3, our caging ligand provides
50% protection of deoxyribose degradation compared to the
background reaction of Cu2+ alone. The photoproducts, on the other
hand, increase the level of OH• produced. The reactivity of the
photoproducts matches that of control reactions run with 1 or 2
equiv of picolinamide, indicating that these bidentate ligands
improve the catalytic properties of the metal with respect to Fenton-
like chemistry. NTA, which has a similar affinity for Cu2+ as
H2cage at this pH, also promotes OH• production by copper (Figure
3). This result highlights the fact that thermodynamic stability alone
does not dictate Fenton reactivity of a metal complex.
In conclusion, we have presented a new photoactive ligand that
can cage copper in a tetracoordinate binding site. Activation with
UV light uncages the metal cargo by cleaving the ligand backbone
to release photoproducts with diminished affinity for Cu2+. The
ability of copper to undergo Fenton-like reactivity and promote OH•
formation increases by 160% following light-induced uncaging. This
is a promising step in developing compounds that are triggered by
light to increase oxidative stress, which is the reverse strategy to
our other efforts to develop chelating agents that can be triggered
to inhibit oxidative stress.13 The caged copper is a neutral compound
with a molecular weight under 500, which may be favorable for
cellular permeability. The 16 pM affinity of our first-generation
caged copper, while significant, may not be strong enough to keep
copper sequestered in the presence of endogenous copper-binding
proteins; for example, human serum albumin binds Cu2+ with 1
pM affinity at pH 7.4.14 Future work is focused on improving the
stability of caged copper complexes, as well as applying photoactive
Acknowledgment. We thank Duke University for support;
K.J.F. acknowledges an NSF CAREER Award; K.L.H. acknowl-
edges an NSF IGERT Fellowship.
Supporting Information Available: Full experimental details and
X-ray crystallographic data including CIF files. This material is available
References
(1) (a) Pen˜a, M. M. O.; Lee, J.; Thiele, D. J. J. Nutr. 1999, 1251–1260. (b)
Gaggelli, E.; Kozlowski, H.; Valensin, D.; Valensin, G. Chem. ReV. 2006,
106, 1995–2044.
(2) (a) Schlief, M. L.; Gitlin, J. D. Mol. Neurobiol. 2006, 33, 81–90. (b) Madsen,
E.; Gitlin, J. D. Annu. ReV. Neurosci. 2007, 30, 317–337.
(3) (a) Wang, T.; Guo, Z. J. Curr. Med. Chem. 2006, 13, 525–537. (b) Filomeni,
G.; Cerchiaro, G.; Da Costa Ferreira, A. M.; De Martino, A.; Pedersen,
J. Z.; Rotilio, G.; Ciriolo, M. R. J. Biol. Chem. 2007, 282, 12010–12021.
(c) Farmer, P. J.; Brayton, D.; Moore, C.; Williams, D.; Shahandeh, B.;
Cen, D.; Meyskens, F. L. In Medicinal Inorganic Chemistry; Sessler, J. L.,
Doctrow, S. R., McMurry, T. J., Lippard, S. J., Eds.; ACS Symposium
Series 903, American Chemical Society: Washington, DC, 2005; p 400-
413.
(4) (a) Kaplan, J. H.; Ellis-Davies, G. C. R. Proc. Natl. Acad. Sci. U.S.A. 1988,
85, 6571–6575. (b) Adams, S. R.; Kao, J. P. Y.; Grynkiewicz, G.; Minta,
A.; Tsien, R. Y. J. Am. Chem. Soc. 1988, 110, 3212–3220.
(5) (a) Ellis-Davies, G. C. R. Chem. ReV. 2008, 108, 1603–1613. (b) Adams,
S. R.; Tsien, R. Y. Annu. ReV. Physiol. 1993, 55, 755–784.
(6) Kishimoto, T.; Liu, T. T.; Ninomiya, Y.; Takagi, H.; Yoshioka, T.; Ellis-
Davies, G. C. R.; Miyashita, Y. W.; Kasai, H. J. Physiol. 2001, 533, 627–
637.
(7) Grell, E.; Warmuth, R. Pure Appl. Chem. 1993, 65, 373–379.
(8) Plaza, P.; Leray, I.; Changenet-Barret, P.; Martin, M. M.; Valeur, B.
ChemPhysChem 2002, 3, 668–674.
(9) Sun, L.; Wu, C. H.; Faust, B. C. J. Phys. Chem. A 1998, 102, 8664–8672.
(10) Conley, H. L.; Martin, R. B. J. Phys. Chem. 1965, 69, 2914–2923.
(11) (a) Stephens, F. S.; Vagg, R. S. Inorg. Chim. Acta 1984, 88, 7–14. (b)
Tsuboyama, S.; Sakurai, T.; Kobayashi, K.; Azuma, N.; Kajikawa, Y.;
Ishizu, K. Acta Crystallogr., Sect. B: Struct. Sci. 1984, 40, 466–473. (c)
Comba, P.; Goll, W.; Nuber, B.; Varnagy, K. Eur. J. Inorg. Chem. 1998,
2041–2049.
(12) Powell, K. J. IUPAC Stability Constants Database, version 5.14; Academic
Software: Yorks, U.K, 2000.
(13) (a) Charkoudian, L. K.; Pham, D. M.; Franz, K. J. J. Am. Chem. Soc. 2006,
128, 12424–12425. (b) Charkoudian, L. K.; Pham, D. M.; Kwan, A.;
Vangeloff, A.; Franz, K. J. Dalton Trans. 2007, 5031–5042.
(14) Rozga, M.; Sokolowska, M.; Protas, A. M.; Bal, W. J. Biol. Inorg. Chem.
2007, 12, 913–918.
JA8047442
9
J. AM. CHEM. SOC. VOL. 130, NO. 37, 2008 12247